• share
• favorite_border

Researchers have developed a new test that could diagnose chronic kidney disease early in patients with type 2 diabetes. This novel method, published today in AACC’s Clinical Chemistry journal, could improve quality of life for diabetic patients by potentially catching chronic kidney disease in time to stop its progression to full-blown kidney failure.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that David G. Grenache, PhD, DABCC, MT(ASCP), FAACC, has been elected to serve on the AACC Board of Directors as president-elect starting in January 2019. Following this, he will serve successive terms as the association’s president from August 2020-July 2021 and as past president from August 2021-July 2022. In addition, the AACC membership elected a new treasurer and two new directors to the association’s Board. They will take office at the start of 2019 along with the incoming president of AACC Academy, who will also serve on the Board.

• share
• favorite_border

AACC welcomed thousands of medical professionals and healthcare leaders at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo from July 29–August 2. The meeting showcased advancements in clinical testing technology and research that improve the ability of healthcare providers to diagnose patients quickly and accurately and ensure that patients get effective medical treatment.

• share
• favorite_border

Novel findings unveiled at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo show that gender-affirming hormone therapy markedly impacts the results of common laboratory tests for transgender patients. This study underscores the need for transgender-specific reference intervals to ensure this underserved population receives accurate diagnoses and effective treatments.

• share
• favorite_border

AACC announced today the launch of a new credential for point-of-care testing professionals. This new certification – the first of its kind in the United States -- is designed for healthcare experts who perform diagnostic tests outside the central laboratory.

• share
• favorite_border

Research announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo reveals that two out of three of the digital home ovulation tests sold by U.S. retailers do not accurately predict when a woman is ovulating. This information is critical for women trying to get pregnant and could improve their chances by helping them to better select at-home tests to guide intercourse timing.

• share
• favorite_border

Researchers have developed a novel test that rapidly distinguishes between type 1 and type 2 diabetes. This new method and a second study revealing gaps in care for women with gestational diabetes were presented today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, and could improve treatment for patients with all diabetes types across the board.

• share
• favorite_border

Scientists have discovered that in rheumatoid arthritis (RA) patients, lower levels of vitamin D are associated with increased disease severity. Their findings, announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, indicate that vitamin D supplementation could significantly improve quality of life for RA patients.

• share
• favorite_border

AACC is pleased to announce the recipients of the AACC 2018 Top Corporate Supporter Awards. This year, AACC recognizes 47 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

• share
• favorite_border

Today biotech innovators will present portable tests that could help more patients get accurate diagnoses in a competition to win AACC’s Disruptive Technology Award.

• share
• favorite_border

SCIEX, a global leader in life science analytical technologies, advanced the accessibility of mass spectrometry in the clinical setting with new product introductions at AACC 2018. Today, SCIEX announced the launch of the new Topaz™ Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes, as well as the new automated Vitamin D 200A Assay Kit.

• share
• favorite_border

At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—trailblazers in the field will share the pioneering research and technology paving the way for better clinical testing and patient care. From July 29–August 2 in Chicago, the meeting will feature more than 200 talks on a broad range of timely healthcare topics.

• share
• favorite_border

Neoteryx LLC today announced research recently published in the official peer-reviewed scientific journal of the European Federation of Clinical Chemistry and Laboratory Medicine, Clinical Chemistry and Laboratory Medicine. The research found that analysis of samples extracted from the company’s VAMS™ technology showed almost perfect agreement with results obtained from venous blood samples for HbA1c levels on a Tosoh G8 analyzer. The investigator-initiated clinical research study took place from June 2017 to January 2018 at Ghent University Hospital in Belgium. The study included 100 patients and was approved by the school’s Ethics Committee.

• share
• favorite_border

Neoteryx LLC, announced today the expansion of its patent-pending Mitra® Microsampling portfolio to now include a 30 µL tip size. The Mitra microsampling device which comes in a 10 µL, 20 µL and now 30 µL holds and transports a precise volume of blood typically collected from a finger prick.

• share
• favorite_border

Today, Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, in the form of the Mitra® microsampling device, to Alcala Labs of San Diego for a more efficacious, streamlined approach to monitor patients in recovery centers throughout the United States. By incorporating VAMS specimen collection and transportation technology into its CleanAssure™ clinical convenience kits and testing menu, Alcala Labs is the first to commercialize an offering to addiction recovery centers that analyzes a volumetrically accurate dried blood microsample collected from a simple finger prick to test for alcohol and opioids.

• share
• favorite_border

Festo AACC 2018 News — Festo introduces a compact rotary gripping module for handling vial and bottle caps. Booth #462

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal, Clinical Chemistry, has risen to 8.636 in the 2017 Thomson Reuters Journal Citation Reports. This impact factor places Clinical Chemistry in the top 2.5% of 12,271 ranked academic journals and speaks to the significant influence of the science it publishes on laboratory medicine and patient care.

• share
• favorite_border

A novel study in AACC’s Clinical Chemistry journal shows that women with a history of gestational diabetes are at increased risk for type 2 diabetes if they eat a diet high in branched-chain amino acids (BCAAs) and can’t metabolize BCAAs effectively. This research could improve diabetes prevention strategies by enabling better identification and more targeted care of women at high risk for this condition.

• share
• favorite_border

Compact and optimized mobility design, fully automated transfer the samples for pipetting, which can directly use whole blood testing. Applied wherever fast quantitative results with full-scale lab quality provide decisive diagnostic advantages, more flexible and suitable for the emergency testing. TS60A is also an ideal supplement for major analysis systems in the central labs.It can be tested in small quantities or in batches at any time without interfering with the processes of routine analysis.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Representative Kevin Yoder (R-Kansas) is the recipient of AACC’s Outstanding Legislator Award for the 115th Congress. This award recognizes Rep. Yoder for his tireless efforts to improve the quality of patient care by advancing harmonization—or uniformity—of clinical laboratory test results.

• share
• favorite_border

The new SmartSled cases for Galaxy Tab Active2, J3 2017, J7 2017, and XCover4 combine protection and functionality for increased efficiency.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2018 AACC and AACC Academy Awards. These annual awards recognize laboratory medicine professionals worldwide for their exceptional research, scholarship, and service in the field, while also raising awareness that laboratory testing is essential to high quality patient care.

• share
• favorite_border

AACC is pleased to see an additional $2 million for lab test harmonization in the FY 2018 omnibus spending package. The association has worked to advance harmonization – or uniform test results -- for more than a decade, most recently leading efforts to raise awareness in Congress of the need for CDC funding for harmonization. AACC is gratified that its multiyear effort has resulted in a positive outcome. The new funding will enable CDC to broaden its harmonization initiative, which is vital to ensuring that patients receive accurate diagnoses and effective medical treatment.

• share
• favorite_border

.A fingerprint test published today in AACC’s Clinical Chemistry journal can tell whether someone has taken heroin or cocaine, and accurately distinguishes between drug users versus individuals who were exposed to drug residue in the environment. This breakthrough study brings fingerprint drug testing one step closer to clinical adoption, which could revolutionize drug testing by making it both simpler and nearly impossible to cheat.

• share
• favorite_border

For the first time, researchers have developed a way to sequence the entire genome of a fetus by modifying the prenatal testing method known as amniocentesis. This groundbreaking finding, published in AACC’s journal Clinical Chemistry, could improve care for genetic diseases in childhood by dramatically increasing the number of these conditions that can be detected during pregnancy.

• share
• favorite_border

As the popularity of the beauty supplement biotin has grown, so has the incidence of this vitamin interfering with critical medical tests. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives expert recommendations to healthcare providers on how to reduce biotin interference with test results to ensure that the many patients taking this supplement receive accurate diagnoses and treatment.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Susan Medick has been named chief financial officer (CFO) for the association, effective today.

• share
• favorite_border

AACC is pleased to announce that Wall Street Journal investigative reporter John Carreyrou will speak about his investigations into the laboratory medicine industry at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.

• share
• favorite_border

A study in AACC’s The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis—or blood clotting—during pregnancy. This research could help lower the high U.S. maternal death rate by enabling more precise identification of pregnant women at risk for thrombosis-related complications such as preeclampsia.

• share
• favorite_border

WASHINGTON – AACC has issued a new guideline detailing how healthcare providers can use laboratory tests to manage treatment of pain and prevent prescription drug overdoses. Especially relevant in light of the worsening opioid epidemic, the guideline emphasizes increased collaboration between clinicians and laboratory experts as well as the use of more precise drug tests as key to identifying pain patients who are abusing their opioid prescriptions.

• share
• favorite_border

A first-of-its-kind study published in the Pain Management issue of AACC’s The Journal of Applied Laboratory Medicine shows that a new drug testing approach dramatically improves detection of illicit benzodiazepine use. This could help to curb abuse of these drugs, which are second only to opioids as a cause of prescription drug overdose deaths in the U.S.

• share
• favorite_border

Innovative research published in the Obesity issue of AACC’s journal, Clinical Chemistry, demonstrates that people are at greater risk for obesity if they produce higher than normal levels of insulin after eating processed carbohydrates. These findings support the still controversial theory that refined carbs are driving the obesity epidemic.

• share
• favorite_border

A special issue of AACC’s The Journal of Applied Laboratory Medicine, “Laboratory Support of Pain Management,” features groundbreaking new drug tests that could reverse the staggering climb of prescription drug overdoses in the U.S.

• share
• favorite_border

Laboratory medicine experts are using genomics, metabolomics, and other cutting-edge clinical testing methods to advance the understanding of obesity. A special issue of AACC’s journal Clinical Chemistry, “Obesity: Innovative Approaches to Overcome Obstacles,” highlights the latest innovations in the field that could lead to more effective public health policies to curb this epidemic.

• share
• favorite_border

Lab Tests Online, AACC’s award-winning public resource on laboratory testing, is pleased to announce that it has launched a dynamic redesign of labtestsonline.org to better help patients, caregivers, and medical professionals understand the many lab tests that are an integral part of healthcare.

• share
• favorite_border

As the use of non-invasive prenatal screening (NIPS) grows, there has been concern within the medical community that a poor understanding of this technique among clinicians and patients could negatively impact pregnancies. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives an expert overview of NIPS’s many nuances, to arm healthcare providers with the information they need to ensure patients benefit from this revolutionary but complex technology.

• share
• favorite_border

Today, AACC sent a letter to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s proposed 2018 rates for clinical test reimbursement under the Protecting Access to Medicare Act (PAMA). In its statement, AACC expresses concern that the new payment rates could significantly limit patient access to crucial medical tests, and urges CMS to revise the rates in order to preserve high quality healthcare.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Carmen L. Wiley, PhD, DABCC, FACB, has been elected to serve on the AACC Board of Directors as president-elect starting in January 2018.

• share
• favorite_border

By enabling early disease detection and personalized treatment, laboratory tests can save lives as well as billions in medical costs each year. Join AACC and leading experts in laboratory medicine for a discussion of how clinical tests can be leveraged to achieve these goals, as well as the policies needed to support testing’s vital contribution to healthcare.

• share
• favorite_border

Attendance at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo reached a record high at this year’s conference in San Diego. Held from July 30-August 3, the meeting featured groundbreaking advances in diagnostic research and technology that will solve a broad range of challenging patient health problems.

• share
• favorite_border

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

• share
• favorite_border

A new study has discovered that two microRNAs could be used to develop the first-ever blood test for kidney cancer as well as novel treatments for this condition. These findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

• share
• favorite_border

Medica Corporation has announced the expanded capability of its EasyRA® clinical chemistry analyzer to now provide drugs of abuse urine screening (DAU). No hardware nor software updates are required, and the added functionality will benefit both current owners and new customers.

• share
• favorite_border

Three-day conference and exposition will bring innovative laboratory science, medicine, and technology to the region, March 22-24, 2018.

• share
• favorite_border

At this year’s American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in San Diego, California on August 2, 2017, Instrumentation Laboratory (IL) will be introducing several breakthrough products.

• share
• favorite_border

Caplugs Evergreen offers a 95-pin single use inoculator assembly to easily transfer samples to a 96-well microplate.

• share
• favorite_border

Sysmex America, Inc., a leading provider of automated hematology and urinalysis diagnostic testing equipment as well as middleware information systems technology, today announced that it has launched its XN-L™ automated hematology analyzers in the United States. The new, smaller XN-L line delivers the same globally-proven, clinical and operational value known in its XN-Series™ to lower volume hematology laboratories. The XN-L analyzers will also be the first to feature BeyondCareSM Quality Monitor, a revolutionary approach to quality assurance. ​

• share
• favorite_border

Clinical laboratories could significantly improve healthcare for the transgender community by using both sex and gender identity to make decisions about clinical testing, and by determining normal lab values for healthy transgender patients. A review published today in AACC’s Clinical Chemistry journal emphasizes these as critical steps on the road to eliminating the many hurdles that transgender individuals face when seeking quality healthcare.

• share
• favorite_border

A review published today in AACC’s Clinical Chemistry journal has identified 10 genes that show promise in predicting how patients will respond to opioid pain medications. Using these genetic markers, healthcare providers could potentially tailor opioid therapy better to curb the skyrocketing rate of deaths from these drugs.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal, Clinical Chemistry, has risen to 8.008 in the 2016 Thomson Reuters Journal Citation Reports. This impact factor places Clinical Chemistry in the top 2.6% of 12,062 ranked academic journals and speaks to the significant influence of the science it publishes on laboratory medicine and patient care.